Reply to Heterogeneity within AML with CEBPA mutations; Only CEBPA double mutations, but not single CEBPA mutations are associated with favorable prognosis

HSIN-AN HOULIANG-IN LINChen, Chien-YuanChien-YuanChenHWEI-FANG TIEN2020-06-162020-06-1620090007-0920https://scholars.lib.ntu.edu.tw/handle/123456789/502703[SDGs]SDG3CD15 antigen; CD56 antigen; CD7 antigen; HLA DR antigen; acute granulocytic leukemia; cancer survival; cebpa gene; gene; gene mutation; human; letter; overall survival; priority journal; prognosis; protein expression; survival rate; CCAAT-Enhancer-Binding Proteins; Disease-Free Survival; DNA Mutational Analysis; Humans; Kaplan-Meiers Estimate; Leukemia, Myeloid, Acute; Mutation; Prognosis; Tumor Markers, BiologicalReply to Heterogeneity within AML with CEBPA mutations; Only CEBPA double mutations, but not single CEBPA mutations are associated with favorable prognosisletter10.1038/sj.bjc.6605207196231752-s2.0-68749110471